A CD2AP mutation associated with focal segmental glomerulosclerosis in young adulthood

Tools

PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB

Item Type:	Article
Title:	A CD2AP mutation associated with focal segmental glomerulosclerosis in young adulthood
Creators Name:	Tsvetkov, D., Hohmann, M., Anistan, Y.M., Mannaa, M., Harteneck, C., Rudolph, B. and Gollasch, M.
Abstract:	Mutations in CD2-associated protein (CD2AP) have been identified in patients with focal segmental glomerulosclerosis (FSGS); however, reports of CD2AP mutations remain scarce. We performed Sanger sequencing in a patient with steroid-resistant FSGS and identified a heterozygous CD2AP mutation (p.T374A, c.1120 A > G). Our patient displayed mild cognitive decline, a phenotypic characteristic not previously associated with CD2AP-associated FSGS. His proteinuria was remarkably reduced by treatment with cyclosporine A. Our findings expand the genetic spectrum of CD2AP-associated disorders and broaden the associated phenotype with the co-occurrence of cognitive decline. Our case shows that cyclosporin A is a treatment option for CD2AP-associated nephropathy.
Keywords:	CD2-Associated Protein (CD2AP), Focal Segmental Glomerulosclerosis, Genetics, Pathology, Steroid-Resistant Nephrotic Syndrome
Source:	Clinical Medicine Insights: Case Reports
ISSN:	1179-5476
Publisher:	Libertas Academica
Volume:	9
Page Range:	15-19
Date:	14 March 2016
Official Publication:	https://doi.org/10.4137/CCRep.S30867
PubMed:	View item in PubMed

Repository Staff Only: item control page

Download Statistics

Downloads

Downloads per month over past year